Opportunity Information: Apply for RFA AI 12 002
Apply for RFA AI 12 002
- The National Institutes of Health in the education health income security and social services sector is offering a public funding opportunity titled "Limited Competition Womens Interagency HIV Study (WIHS V) (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.279 Drug Abuse and Addiction Research Programs 93.396 Cancer Biology Research 93.855 Allergy and Infectious Diseases Research 93.856 Microbiology and Infectious Diseases Research 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Nov 29, 2011 and posted on Nov 29, 2011.
- Applicants must submit their applications by Feb 22, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $23,900,000.00 to eligible and selected applicants.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following U01 AI 35004, Bronx, NY (Montefiore Medical Center) U01 AI 31834, Brooklyn, NY (SUNY Downstate Medical Center) U01 AI 34993, Chicago, IL (Hektoen Institute for Medical Research) U01 HD 32632, Los Angeles, CA (University of Southern California) U01 AI 34989, San Francisco, CA (University of California San Francisco) U01 AI 34994, Washington, DC (Georgetown University) U01 AI 42590, Baltimore, MD, (Johns Hopkins University) (as the WIHS Data Management and Analysis Center (WDMAC) Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Limited Competition Womens Interagency HIV Study (WIHS V) (U01) grant opportunity (Funding Opportunity Number RFA-AI-12-002) is a National Institutes of Health (NIH) cooperative agreement aimed at continuing and expanding a major U.S. epidemiologic cohort focused on women affected by HIV. The central goal of WIHS V is to document and better understand the long-term course of HIV infection in women over time, including both the natural history of infection and outcomes under modern treatment. Just as importantly, the initiative is designed to refresh and strengthen the cohort by recruiting and retaining new participants so the study reflects shifting realities in the U.S. HIV epidemic among women, including changes in demographics, geography, and clinical patterns as treatment and prevention evolve.
This is a limited competition, meaning it is not broadly open to all institutions. NIH is specifically inviting applications from the existing WIHS Clinical Research Sites (CRS), from the current WIHS Data Management and Analysis Center (WDMAC), and from one additional, new Clinical Research Site located in and able to enroll targeted populations of women from the Southern United States. The eligible Southern-region states are restricted to Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Texas. The emphasis on the South reflects a strategic interest in ensuring that the cohort captures women from a region that has carried a substantial and in many areas growing burden of HIV, and where the epidemic can look different in terms of access to care, socioeconomic factors, and affected communities.
Because the award mechanism is a U01 cooperative agreement, recipients should expect substantial programmatic involvement from NIH compared with a typical research project grant. In practical terms, WIHS V is structured as a coordinated network in which the funded sites and the data management center operate together as parts of a single, integrated cohort study. The announcement makes clear that all awards made under this FOA collectively form the WIHS V epidemiologic cohort, underscoring that the intent is not to fund disconnected projects but to maintain a unified, standardized research platform capable of producing comparable data across locations and over time.
The opportunity is categorized as discretionary funding and sits within broad activity areas that include education, health, and income security/social services. The listed CFDA program areas span multiple NIH-related research domains, including mental health (93.242), drug abuse and addiction research (93.279), cancer biology (93.396), allergy and infectious diseases (93.855), microbiology and infectious diseases (93.856), and child health and human development extramural research (93.865). This range signals that the cohort is expected to support multidisciplinary research questions relevant to women living with or at risk for HIV, including comorbidities and intersecting conditions that commonly influence outcomes over the long term.
The estimated total funding level for the FOA is approximately $23.9 million, and there is no cost-sharing or matching requirement. The announcement was posted on November 29, 2011, with an original and current closing date of February 22, 2012, and an archive date of March 24, 2012. Eligibility is narrowly defined: specific existing awardee institutions tied to prior WIHS U01 awards are listed as eligible applicants, including Montefiore Medical Center (Bronx, NY), SUNY Downstate Medical Center (Brooklyn, NY), Hektoen Institute for Medical Research (Chicago, IL), University of Southern California (Los Angeles, CA), University of California San Francisco (San Francisco, CA), Georgetown University (Washington, DC), and Johns Hopkins University (Baltimore, MD) as the Data Management and Analysis Center. The FOA also explicitly excludes non-U.S. entities, non-U.S. components of U.S. organizations, and foreign components as defined by NIH policy, reinforcing that this cohort effort is intended to be conducted entirely within the United States.
Overall, WIHS V is best understood as continued federal support for a long-running, highly coordinated national cohort designed to generate rigorous longitudinal evidence about HIV in women, while updating and expanding recruitment to reflect where and among whom the epidemic is occurring now. The structure of the FOA highlights both continuity (supporting existing sites and the established data center) and targeted expansion (adding a Southern clinical research site) to ensure the cohort remains scientifically useful, geographically relevant, and representative of changing U.S. demographics.
Frequently Asked Questions (FAQs) - Limited Competition Womens Interagency HIV Study (WIHS V) (U01)
What is the WIHS V (U01) funding opportunity?
WIHS V is a National Institutes of Health (NIH) cooperative agreement (U01) intended to continue and expand a major U.S. epidemiologic cohort focused on women affected by HIV. It supports a coordinated, multi-site effort designed to generate comparable longitudinal data across locations and over time.
What is the Funding Opportunity Number (FOA number) for this grant?
The Funding Opportunity Number is RFA-AI-12-002.
What is the main goal of WIHS V?
The central goal is to document and better understand the long-term course of HIV infection in women over time, including the natural history of infection and outcomes under modern treatment.
Why does WIHS V emphasize recruiting and retaining new participants?
The initiative is designed to refresh and strengthen the cohort so it reflects shifting realities in the U.S. HIV epidemic among women, including changes in demographics, geography, and clinical patterns as treatment and prevention evolve.
Is this opportunity open to all institutions?
No. This is a limited competition and is not broadly open to all institutions.
Who is eligible to apply?
NIH is specifically inviting applications from: (1) the existing WIHS Clinical Research Sites (CRS), (2) the current WIHS Data Management and Analysis Center (WDMAC), and (3) one additional, new Clinical Research Site located in the Southern United States (as defined in the FOA description).
Which existing institutions are listed as eligible applicants?
The eligible applicants listed include Montefiore Medical Center (Bronx, NY), SUNY Downstate Medical Center (Brooklyn, NY), Hektoen Institute for Medical Research (Chicago, IL), University of Southern California (Los Angeles, CA), University of California San Francisco (San Francisco, CA), Georgetown University (Washington, DC), and Johns Hopkins University (Baltimore, MD) as the Data Management and Analysis Center.
What is the geographic focus for the new Clinical Research Site?
The FOA includes one additional, new Clinical Research Site that must be located in and able to enroll targeted populations of women from the Southern United States.
Which Southern states are eligible for the new Clinical Research Site?
The eligible Southern-region states are Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Texas.
Why is the Southern United States specifically emphasized?
The emphasis reflects an interest in ensuring the cohort captures women from a region with a substantial (and in many areas growing) HIV burden, where experiences may differ due to access to care, socioeconomic factors, and affected communities.
What does it mean that this award uses a U01 cooperative agreement mechanism?
A U01 cooperative agreement indicates substantial programmatic involvement from NIH compared with a typical research project grant. Under WIHS V, funded sites and the data management center are expected to operate as a coordinated network rather than as disconnected projects.
Is WIHS V intended to fund separate independent projects at different locations?
No. The FOA states that all awards made under this announcement collectively form the WIHS V epidemiologic cohort, indicating the intent is to maintain a unified, standardized research platform with comparable data across sites.
How is WIHS V structured operationally?
It is structured as an integrated cohort study network in which the funded Clinical Research Sites and the Data Management and Analysis Center work together as parts of one coordinated effort.
What type of funding category is this opportunity listed under?
The opportunity is categorized as discretionary funding.
What broad activity areas are associated with this opportunity?
The activity areas include education, health, and income security/social services.
Which CFDA program areas are associated with this FOA?
The listed CFDA program areas span multiple NIH-related research domains, including mental health (93.242), drug abuse and addiction research (93.279), cancer biology (93.396), allergy and infectious diseases (93.855), microbiology and infectious diseases (93.856), and child health and human development extramural research (93.865).
What does the range of CFDA areas imply about the research supported by the cohort?
The range suggests the cohort is expected to support multidisciplinary research questions relevant to women living with or at risk for HIV, including comorbidities and intersecting conditions that influence long-term outcomes.
What is the estimated total funding level for this FOA?
The estimated total funding level is approximately $23.9 million.
Is cost-sharing or matching required?
No. The FOA indicates there is no cost-sharing or matching requirement.
When was this opportunity posted?
The announcement was posted on November 29, 2011.
What is the application closing date?
The original and current closing date listed is February 22, 2012.
When was the FOA archived?
The archive date is March 24, 2012.
Are non-U.S. organizations eligible to apply?
No. The FOA explicitly excludes non-U.S. entities.
Are non-U.S. components of U.S. organizations allowed to participate?
No. The FOA excludes non-U.S. components of U.S. organizations and foreign components as defined by NIH policy, indicating the cohort effort is intended to be conducted entirely within the United States.
What is WIHS V in plain terms?
WIHS V is continued federal support for a long-running, highly coordinated national cohort designed to produce rigorous longitudinal evidence about HIV in women, while updating and expanding recruitment (including targeted expansion into the Southern U.S.) to stay representative of current U.S. epidemic patterns.
Browse more business programs for Women in Business
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health Income Security and Social Services
Next opportunity: International Research Collaboration on Drug Abuse and Addiction Research (R01)
Previous opportunity: Portable Assistance Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AI 12 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AI 12 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Solicitation of Assays for High Throughput Screening (HTS) to Discover Chemical Probes (R21) Apply for PAR 12 059 Funding Number: PAR 12 059 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Solicitation of Validated Hits for the Discovery of in vivo Chemical Probes (R01) Apply for PAR 12 060 Funding Number: PAR 12 060 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32) Apply for PAR 12 084 Funding Number: PAR 12 084 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Research on the Health of LGBTI Populations R01 Apply for PA 12 111 Funding Number: PA 12 111 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Research on the Health of LGBTI Populations R03 Apply for PA 12 112 Funding Number: PA 12 112 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $50,000 |
| Research on the Health of LGBTI Populations (R21) Apply for PA 12 113 Funding Number: PA 12 113 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Research on Emergency Medical Services for Children (EMSC) R21 Apply for PA 12 142 Funding Number: PA 12 142 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Research on Emergency Medical Services for Children (EMSC) R01 Apply for PA 12 141 Funding Number: PA 12 141 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Multidisciplinary Studies of HIV/AIDS and Aging (R21) Apply for PAR 12 174 Funding Number: PAR 12 174 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Multidisciplinary Studies of HIV/AIDS and Aging (R03) Apply for PAR 12 176 Funding Number: PAR 12 176 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $100,000 |
| Womens Mental Health During Pregnancy and the Postpartum Period (R21) Apply for PA 12 215 Funding Number: PA 12 215 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Womens Mental Health During Pregnancy and the Postpartum Period (R01) Apply for PA 12 216 Funding Number: PA 12 216 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Research on Children in Military Families The Impact of Parental Military Deployment and Reintegration on Child and Family Functioning (R13) Apply for PA 12 223 Funding Number: PA 12 223 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $25,000 |
| Ethical Issues in Research on HIV/AIDS and its Co morbidities (R01) Apply for PAR 12 244 Funding Number: PAR 12 244 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Ethical Issues in Research on HIV/AIDS and its Co morbidities (R21) Apply for PAR 12 243 Funding Number: PAR 12 243 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| Human Heredity and Health in Africa (H3Africa) H3Africa Research Grants (U01) Apply for RFA RM 12 007 Funding Number: RFA RM 12 007 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $350,000 |
| U.S. Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and Co morbidities (R21) Apply for RFA DA 14 001 Funding Number: RFA DA 14 001 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $200,000 |
| International Research Ethics Education and Curriculum Development Award (R25) Apply for PAR 13 027 Funding Number: PAR 13 027 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: Case Dependent |
| Opportunities for Collaborative Research at the NIH Clinical Center (U01) Apply for PAR 13 029 Funding Number: PAR 13 029 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $500,000 |
| Prevention and Health Promotion Interventions to Prevent Alcohol and Other Drug Abuse and Associated Physical and Psychological Health Problems in U.S. Military Personnel, Veterans and their Families (R34) Apply for RFA DA 13 013 Funding Number: RFA DA 13 013 Agency: National Institutes of Health Category: Education Health Income Security and Social Services Funding Amount: $225,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 12 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
